Home/Filings/4/0001415889-24-002379
4//SEC Filing

Hannah Brendan 4

Accession 0001415889-24-002379

CIK 0001662774other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 5:53 PM ET

Size

5.7 KB

Accession

0001415889-24-002379

Insider Transaction Report

Form 4
Period: 2024-02-01
Hannah Brendan
CBO, COO and CCO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2024-02-01+600,000600,000 total
    Exercise: $1.31Exp: 2034-01-31Common Stock (600,000 underlying)
Footnotes (1)
  • [F1]The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of the vesting commencement date of January 1, 2024, such that the total number of shares shall be fully vested on the four-year anniversary of the vesting commencement date.

Issuer

Quince Therapeutics, Inc.

CIK 0001662774

Entity typeother

Related Parties

1
  • filerCIK 0001929422

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:53 PM ET
Size
5.7 KB